Latest Market Development News

Australian Vanadium Limited has responded to an ASX price query following a sharp rise in its share price and trading volume, denying any undisclosed information behind the market activity.

Tamawood Limited has reported a robust interim financial performance for the half year ended December 2025, showcasing significant growth in revenue, profit, and net tangible assets per share. The company’s reinstated dividend reinvestment plan and upcoming dividend review add to investor interest.

Impact Minerals has identified a promising standalone process to produce sulphate of potash and hydrochloric acid from lake clays in Western Australia, potentially reducing reliance on imports and addressing local industrial demand.

Vitrafy Life Sciences has delivered key milestones in the first half of FY26, including a strategic partnership with IMV Technologies and progress in clinical studies, while maintaining a strong cash position to support its U.S. expansion and product launches.

Cyclopharm has reported a record $32.3 million in operating revenue for FY2025, led by explosive growth in its U.S. Technegas market following FDA approval. The company reaffirms its ambitious target of 250–300 U.S. installations by mid-2026 amid strong clinical momentum.

New Frontier Minerals has completed the Stage 1 earn-in to secure an 85% interest in a pivotal tenement at its Harts Range Heavy Rare Earths Project, positioning the company strongly ahead of imminent assay results.

Pure One Corporation Limited has advanced its zero-emission mobility strategy with a new local vehicle assembly partnership, expanded US hydrogen market collaborations, and progressed the spin-out of its Australian gas assets via Eastern Gas IPO.

Resonance Health has reported record half-year revenue and strong progress in clinical trials, alongside promising new technology deployments set to enhance its global footprint.

Pacific Lime and Cement Limited reports steady progress on its Central Lime Project in Papua New Guinea, securing key government agreements and strategic partnerships while maintaining financial discipline.

PLS Group Limited posted a robust December Quarter FY26 with a 49% revenue jump driven by higher sales volumes and improved lithium prices, while strategically reviewing growth projects amid evolving market conditions.

Little Green Pharma reports record quarterly revenue and announces a transformative merger with Cannatrek, creating a leading vertically integrated medicinal cannabis group with strong European growth prospects.

Jatcorp Limited reported a striking 165% revenue increase in Q2 FY26, driven by strong demand in Australia, Hong Kong, and China. The company also secured $4.2 million through an entitlement offer to support its growth ambitions across Southeast Asia.